Corinna Singleman

Proposed NIH funding cuts are a pressing concern when one considers the broader impacts of reduced research funding.

Little is known about the genetics of Anopheles funestus, one of the most prolific malaria-transmitting mosquitos in sub-Saharan Africa.

Single-cell proteomics with RNA sequencing uncover hidden gene expression dynamics in stem cell differentiation.

The newly designed antibody transport vesicle holds promise as a potential solution to the challenges of current AD therapies.

Large-scale redesigns, including changes to core domains, may retain stability—challenging assumptions that such regions are off-limits.

A newly developed generative AI model is helping researchers explore protein dynamics with increased speed.

The duration of expression of the gene Cdx2 is tightly regulated by a newly identified DNA sequence element called an “attenuator.”

By designing proteins de novo scientists can more efficiently create novel therapeutics tailored for specific biological functions.

Massively Parallel Ribosome Profiling (MPRP) enables rapid identification of viral proteins without the need to grow live viruses.

The increased genetic complexity and similarity to adult cancers’ genetic diversity could also present new therapeutic opportunities.

The virus likely reached humans not via bat migration but through the wildlife trade—contradicting hypotheses that it may have lab origins.

A small shift in nutrient supply has led to the development of a new method to rejuvenate stem cells.

Researchers identified how a brain circuit involving dopamine and GLP-1 receptor impact palatability and hedonic eating.

Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.

GEN editors discuss both the news and history of DNA and genetic engineering in this episode of the Touching Base Podcast.

The crowd was loud and energized, speaking in one unified voice with a major message: “Science, not silence.”

This approach could transform radiation therapy by allowing higher doses to be used more safely, ultimately improving outcomes for cancer patients.

MIT researchers suggests a potential molecular strategy for treating fragile X syndrome by enhancing NMDA subunit function.

New research uses AI to engineer enzymes with intricate active sites, expanding the possibilities for synthetic biocatalysts.

Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes.